Condition
Hepatobiliary Cancers Liver
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
75.0%
3 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Terminated3
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT00767936Terminated
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
NCT01071434Terminated
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
NCT01031056Withdrawn
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT00768001Terminated
Genetic Analysis of Liver Cancer
Showing all 4 trials